Product
Onivyde
2 clinical trials
1 indication
Indication
Pancreatic CancerClinical trial
A Phase 2 Study of Cabiralizumab (BMS-986227, FPA008) Administered in Combination With Nivolumab (BMS-936558) With and Without Chemotherapy in Patients With Advanced Pancreatic CancerStatus: Completed, Estimated PCD: 2023-06-01
Clinical trial
A Phase IIa, Multicenter, Open-label Study to Assess the Safety and Efficacy of the Combination of BL-8040 and Pembrolizumab in Patients With Metastatic Pancreatic Cancer, the COMBAT StudyStatus: Completed, Estimated PCD: 2022-09-06